keyword
https://read.qxmd.com/read/34420138/exploratory-analysis-of-clinical-benefit-of-ipilimumab-and-nivolumab-treatment-in-patients-with-metastatic-melanoma-from-a-single-institution
#1
JOURNAL ARTICLE
C M Vila, F A Moreno, M M Estébanez, G R Ares, G Villacampa, P Dashti, H S Oberoi, R Martin-Huertas, P Jares, L Alos, C Teixido, R Rull, M Sanchez, J Malvehy, E Carcelero, I Valduvieco, A A Fernandez
PURPOSE: We retrospectively analysed overall survival (OS) and potential predictive biomarkers of OS in patients with metastatic melanoma treated with ipilimumab plus nivolumab in a single institution. METHODS AND PATIENTS: Electronic medical records of patients with advanced melanoma receiving ≥ 1 dose of a combined ipilimumab plus nivolumab regimen between March 3, 2016 and March 7, 2020 in a single institution, were reviewed. OS was analysed using the Kaplan-Meier method...
February 2022: Clinical & Translational Oncology
https://read.qxmd.com/read/33498057/combination-of-allergic-asthma-symptom-and-medication-scores-in-allergen-immunotherapy-trials-a-proposal
#2
JOURNAL ARTICLE
Raquel Caballero, Alicia Grau, Gracia Javaloyes, Sandra Del Pozo, Miguel-Ángel León, Marta Romero, Miguel Casanovas
No abstract text is available yet for this article.
2021: International Archives of Allergy and Immunology
https://read.qxmd.com/read/32084720/palbociclib-induced-senescence-upregulates-the-expression-of-il-8-and-may-enhance-the-response-to-inmunotherapy
#3
JOURNAL ARTICLE
A Martinez Bueno, J Bertran Aramillo, J J Garcia Mosquera, A Gimenez Capitan, J Codony-Servat, A Aguilar, S Garcia Román, C Mayo de Las Casas, S Viteri, M A Molina
No abstract text is available yet for this article.
May 2019: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/31130304/new-oncologic-emergencies-what-is-there-to-know-about-inmunotherapy-and-its-potential-side-effects
#4
REVIEW
Arantzazu Barquín-García, Javier Molina-Cerrillo, Pilar Garrido, Daniel Garcia-Palos, Alfredo Carrato, Teresa Alonso-Gordoa
Over the last decade anticancer treatment has experienced encouraging changes. One of the latest developments is immunotherapy, which is increasingly becoming a mainstay for the treatment of these malignancies. Unlike conventional chemotherapy, immunotherapy enhances anti-tumor immune response by blocking inhibitory immune checkpoints, and allowing our own immune system to fight against the tumor cells, arising as a new and innovative mechanism of action. Therefore, although well tolerated, these drugs have a unique side effect profile and are known to cause immune-related adverse events (irAEs)...
August 2019: European Journal of Internal Medicine
https://read.qxmd.com/read/30855023/inmunotherapy-in-prostate-cancer
#5
REVIEW
Inês Anselmo da Costa, Arnulf Stenzl, Jens Bedke
Prostate cancer (PCa) is the second most commonly diagnosed cancer. Although systemic chemotherapeutic agents, such as cabazitaxel, abiraterone and enzalutamde have become available to patients over the last decade, metastatic PCa is still an incurable disease. Immunotherapy is showing great promise in a wide range of other cancer types. To this day, the only immunotherapy approved by the FDA for PCa is the Sipuleucel-T vaccine, which showed significant clinical efficacy. Multiple clinical studies on immunotherapy in PCa are currently underway...
March 2019: Archivos Españoles de Urología
https://read.qxmd.com/read/26239334/-allergy-to-egg-proteins-in-children
#6
JOURNAL ARTICLE
Marco Antonio Góngora-Meléndez, Armando Magaña-Cobos, Juan Manuel Montiel-Herrera, Cinthya Lorena Pantoja-Minguela, Mario Luis Pineda-Maldonado, Eduardo Enrique Piñeyro-Beltrán
Food allergy prevalence has increased during the last years, affecting 15-20% of children, in this case, egg allergy affects from 0.5-2.5%. Most of the egg allergic reactions are type I or IgE mediated antibodies against egg proteins. Five major proteins have been identified: ovomucoid (Gal d1), ovoalbumin (Gal d2), ovotransferrin (Gal d3), lysozyme (Gal d4) and albumin (Gal d5). Ovomucoid protein, which is found in the egg white, is heat resistant and enzyme resistant. This protein is the most allergenic and the most common in egg composition...
July 2015: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/18445082/cluster-immunotherapy-with-a-glutaraldehyde-modified-mixture-of-grasses-results-in-an-improvement-in-specific-nasal-provocation-tests-in-less-than-2-5-months-of-treatment
#7
RANDOMIZED CONTROLLED TRIAL
J Subiza, A Feliú, J L Subiza, J Uhlig, E Fernández-Caldas
BACKGROUND: Cluster immunotherapy is becoming increasingly used. It allows for a rapid build up phase and the administration of higher doses of allergen in a shorter period of time. OBJECTIVES: To evaluate the effect of short-term pre-seasonal immunotherapy using a glutaraldeyde-modified allergen vaccine in reducing specific nasal hyperreactivity in nasal challenge tests. MATERIALS AND METHODS: Thirty-three patients were selected. All patients had a positive history of allergic rhinitis and skin tests to grass pollen, although most of them (72...
June 2008: Clinical and Experimental Allergy
https://read.qxmd.com/read/16353545/-some-immunological-aspects-in-the-reaccional-states-of-hansen-disease
#8
REVIEW
Elsa Rada, Aranzazu Nacarid, Jacinto Convit
The crucial clinical problem in leprosy is represented by episodes of intense inflammation that produce nerve damage. When Mycobacterium leprae has been eliminated by means of antibiotics, the death of the bacteria is not a complete solution to the damage caused in nerves. Two of the more frequent immunopathological phenomena in Hansen's disease are Type I, reactions, known as Reversal Reactions (RR), and Type II reactions, of which the most frequent and well known are those called Erythema Nodosum Leprosum (ENL)...
December 2005: Investigación Clínica
https://read.qxmd.com/read/16180312/-atypical-sites-of-metastatic-renal-carcinoma-literature-review
#9
REVIEW
D A Pérez Fentes, M Blanco Parra, V Toucedo Caamaño, J Lema Grille, A Cimadevila García, M Villar Núñez
OBJECTIVE: To review in the literature atypical sites of metastatic renal cell carcinoma, its onset, clinical features, diagnosis, treatment and prognosis. METHODS: To review, using Medline database, atypical sites of metastatic renal cell carcinoma in the last five years Spanish literature. RESULTS: There have been published 15 spanish articles about atypical metastatic renal cell carcinoma in the last five years. Most patients were male with a mean age of 62,3 years and methacronous metastases...
July 2005: Actas Urologicas Españolas
https://read.qxmd.com/read/6950685/-maintenance-chemotherapy-and-inmunotherapy-in-acute-lymphoblastic-leukemia-author-s-transl
#10
JOURNAL ARTICLE
J J Ortega, G Javier
UNLABELLED: Sixty-one children with ALL were treated between 1970 an 1973 according to a scheme including: a) Remission induction with vincristine-prednisolone-daunorubicine. b) Cytoreduction therapy with 4 drugs (6-MP, MTX,Ara-C and CYCLO) combined two by two in 3 types of associations given at three months cycles. Every three months, two-week "reinductions" with vincristine and prednisolone plus one dose of i.t. MTX. c) Early therapy on CNS, according to two patterns: one group received one dose of i...
October 1981: Anales Españoles de Pediatría
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.